Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 501692-44-0
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: TON
CAS NO:: |
501692-44-0 |
Appearance:: |
Solid Powder |
Molecular Formula:: |
C37H48N4O8S2 |
Molecular Weight:: |
740.9290 |
EINECS NO:: |
NA |
MDL NO:: |
NA |
CAS NO:: |
501692-44-0 |
Appearance:: |
Solid Powder |
Molecular Formula:: |
C37H48N4O8S2 |
Molecular Weight:: |
740.9290 |
EINECS NO:: |
NA |
MDL NO:: |
NA |
Product Description:
Product Name: odevixibat CAS NO: 501692-44-0
Synonyms:
1,1-dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-(N-{(R)-α-[N-((S)-1-carboxypropyl)carbamoyl]-4-hydroxybenzyl}carbamoylmethoxy)-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine;
Chemical & Physical Properties:
Appearance: Solid powder
Assay :≥98.0%
Density: Density: 1.3±0.1 g/cm3
Index of Refraction: 1.643
Storage Powder: -20℃ 12 Months; 4°C 6 Months
Boiling Point: NA
Melting Point: NA
Flash Point: NA
Refractive Index: NA
Storage Condition: NA
Safety Information:
Hazardous decomposition products: Under fire conditions, may decompose and emit toxic fumes.Other decomposition products - no data available.
A4250 (A-4250, Odevixibat) is a small molecule ileal bile acid transporter (IBAT) inhibitor for the treatment of cholestatic liver diseases including progressive familial intrahepatic cholestasis and NASH. Other Indication Phase 3 Clinical.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
